Nexalin Technology Stock Today
| NXL Stock | USD 1.19 0.04 3.48% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Nexalin Technology is selling for 1.19 as of the 17th of June 2025. This is a 3.48% up since the beginning of the trading day. The stock's lowest day price was 1.13. Nexalin Technology has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 18th of May 2025 and ending today, the 17th of June 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 16th of September 2022 | Category Healthcare | Classification Health Care |
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company was incorporated in 2021 and is headquartered in Houston, Texas. Nexalin Technology operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 17.18 M outstanding shares of which 125.04 K shares are now shorted by investors with about 1.05 days to cover. More on Nexalin Technology
Moving against Nexalin Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Nexalin Stock Highlights
| CEO, President | Mark White | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Australia All Ordinaries, NASDAQ Composite, NASDAQ Health Care, SPASX All Technology, SPASX All Australian, SPASX 300, ASX Small Ordinaries, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsNexalin Technology can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Nexalin Technology's financial leverage. It provides some insight into what part of Nexalin Technology's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Nexalin Technology (NXL) is traded on NASDAQ Exchange in USA. It is located in 1776 Yorktown, Houston, TX, United States, 77056 and employs 6 people. Nexalin Technology is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 19.75 M. Nexalin Technology runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 17.18 M outstanding shares of which 125.04 K shares are now shorted by investors with about 1.05 days to cover.
Nexalin Technology has about 291.33 K in cash with (3.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Check Nexalin Technology Probability Of Bankruptcy
Ownership AllocationNexalin Technology maintains a total of 17.18 Million outstanding shares. Nexalin Technology secures 15.81 % of its outstanding shares held by insiders and 2.28 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nexalin Ownership Details
Nexalin Technology Historical Income Statement
Nexalin Stock Against Markets
Nexalin Technology Corporate Management
| Marilyn Elson | Chief Officer | Profile | |
| Joel Bradus | Director Marketing | Profile | |
| Carolyn Shelton | Regulatory Quality | Profile | |
| David MD | Chief Director | Profile | |
| Michael Nketiah | Regulatory Quality | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.84) | Revenue Per Share | Quarterly Revenue Growth (0.48) | Return On Assets | Return On Equity |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.